Valeant

Valeant Pharmaceuticals Intl Inc (VRX) Soars As Debt Deal Reached

Valeant Pharmaceuticals Intl Inc (VRX) obtained consent from over half of loan holders to push back regulatory filing deadlines and loosen financial conditions on the loans. The week marks a series of positive developments for the struggling drug maker and, mirroring the positive developments, Valeant shares surged $5.44, or 19% Wednesday to close at $34.17, making the latest increase the biggest one-day percentage jump since Sept. 9, 2005. Shares are up again about 7 percent today on news that it secured a commitment from loan . . .

SORRY!

This content is exclusively for paying members. Access all of our content on including years of timeless investment news and in depth analysis for only a few dollars a month by signing up here while also supporting quality content and journalism, or learn more about our premium content here

If you are subscribed and having an account error please clear cache and then cookies if that does not work email support@valuewalk.com and we will get back to you as quick as humanly possible


Saved Articles
X
TextTExtLInkTextTExtLInk

Subscribe to our mailing list

* indicates required

Opt out of occasional 3rd party offers


0